Data / Form D filings / Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc.: Form D filings
Ensysce Biosciences, Inc., a health care company in La Jolla, CA, filed 8 Form D notices with the SEC between 2021 and 2026. The latest, on August 20, 2026, reports $77.2 million sold of a $77.2 million offering to 44 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7946 IVANHOE AVE, SUITE 201, La Jolla, CA, 92037
- Phone
- (858) 263-4196
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1716947
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | New notice | $77,200,000 | $77,200,000 | 44 | Aug 5, 2026 | sec.gov | |
| Apr 25, 2025 | New notice | $2,200,012 | $2,200,012 | 8 | Apr 23, 2025 | sec.gov | |
| Apr 14, 2025 | New notice | $1,100,000 | $1,100,000 | 8 | Mar 31, 2025 | sec.gov | |
| Sep 12, 2024 | New notice | $5,055,648 | $5,055,648 | 4 | Aug 29, 2024 | sec.gov | |
| Feb 21, 2024 | New notice | $4,718,295 | $4,718,295 | 4 | Feb 14, 2024 | sec.gov | |
| Mar 1, 2023 | New notice | $2,816,073 | $2,816,073 | 8 | Feb 2, 2023 | sec.gov | |
| Jul 8, 2022 | New notice | $8,480,000 | $4,240,000 | $4,240,000 | 3 | Jun 30, 2022 | sec.gov |
| Oct 6, 2021 | New notice | $15,900,000 | $5,300,000 | $10,600,000 | 3 | Sep 24, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| D Lynn Kirkpatrick | Executive Officer, Director | |
| Bob Gower | Director | |
| William Chang | Director | |
| Steve Martin | Director | |
| Adam Levin | Director | |
| David Humphrey | Executive Officer | |
| James Morrison | Executive Officer, Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Ensysce Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.